Virbac has announced sales of 1247 ME for the 2023 financial year, up 2.5% on 2022 and +4.9% at constant exchange rates and scope of consolidation.

Operating income before non-recurring items stands at 185 ME (+1.1%), while net income, Group share, is virtually stable at 121.3 ME (vs. 121.9 ME in 2022).

'In 2024, at constant exchange rates and scope of consolidation, we anticipate an adjusted Ebit/sales ratio of around 15%, and sales growth estimated, at this stage, at between 4% and 6%', says the company.

Virbac reaffirms its ambition to achieve an adjusted Ebit ratio of 20% by 2030.

The company adds that a net dividend of E1.32 per share will be proposed to the next Annual General Meeting of Shareholders in respect of the 2023 financial year.

Copyright (c) 2024 CercleFinance.com. All rights reserved.